亨迪药业
(301211)
| 流通市值：13.69亿 | | | 总市值：54.75亿 |
| 流通股本：7200.00万 | | | 总股本：2.88亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 333,993,687.09 | 241,866,955.11 | 138,059,120.72 | 663,025,874.35 |
| 营业收入 | 333,993,687.09 | 241,866,955.11 | 138,059,120.72 | 663,025,874.35 |
| 二、营业总成本 | 263,843,342.98 | 164,433,150.68 | 94,973,688.59 | 467,721,232.76 |
| 营业成本 | 233,021,231.04 | 154,786,688.6 | 85,712,253.52 | 396,674,551.96 |
| 税金及附加 | 2,863,447.78 | 2,203,693.25 | 575,610.77 | 5,915,750.28 |
| 销售费用 | 16,568,821.74 | 10,400,457.42 | 5,879,698.08 | 24,083,987.5 |
| 管理费用 | 29,226,852.36 | 19,233,289.54 | 9,603,348.46 | 38,887,669.74 |
| 研发费用 | 26,268,412.71 | 19,295,692.65 | 10,942,220.83 | 52,774,555.54 |
| 财务费用 | -44,105,422.65 | -41,486,670.78 | -17,739,443.07 | -50,615,282.26 |
| 其中:利息费用 | 183,046.45 | 125,051.9 | 63,250.86 | 307,434.08 |
| 其中:利息收入 | 43,297,639.2 | 39,577,889.64 | 17,106,058 | 47,836,359.02 |
| 加:公允价值变动收益 | 10,081,549.98 | 2,650,583.31 | 947,916.62 | 4,020,138.87 |
| 加:投资收益 | 1,178,016.32 | 975,104.2 | 34,437.52 | - |
| 资产处置收益 | - | - | - | 177,180.61 |
| 信用减值损失(新) | -666,967.66 | -614,544.91 | -326,500.71 | 596,608.83 |
| 其他收益 | 2,215,080.91 | 684,822.41 | 599,479.25 | 5,235,500.22 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 82,958,023.66 | 81,129,769.44 | 44,340,764.81 | 205,334,070.12 |
| 加:营业外收入 | 84,432.93 | 84,432.93 | 52,082.43 | 299,281.44 |
| 减:营业外支出 | 461,899.76 | 329,029.87 | 69,254.26 | 2,817,251.22 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 82,580,556.83 | 80,885,172.5 | 44,323,592.98 | 202,816,100.34 |
| 减:所得税费用 | 7,919,010.55 | 12,389,161.19 | 6,941,995.78 | 26,699,898.67 |
| 六、净利润 | 74,661,546.28 | 68,496,011.31 | 37,381,597.2 | 176,116,201.67 |
| 持续经营净利润 | 74,661,546.28 | 68,496,011.31 | 37,381,597.2 | 176,116,201.67 |
| 归属于母公司股东的净利润 | 74,661,546.28 | 68,496,011.31 | 37,381,597.2 | 176,116,201.67 |
| (一)基本每股收益 | 0.26 | 0.24 | 0.13 | 0.61 |
| (二)稀释每股收益 | 0.26 | 0.24 | 0.13 | 0.61 |
| 九、综合收益总额 | 74,661,546.28 | 68,496,011.31 | 37,381,597.2 | 176,116,201.67 |
| 归属于母公司股东的综合收益总额 | 74,661,546.28 | 68,496,011.31 | 37,381,597.2 | 176,116,201.67 |
| 公告日期 | 2024-10-28 | 2024-08-29 | 2024-04-29 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |